Dear Editor,
In recent months, additional Omicron variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), including the BA.5 sublineage BF.7 and BQ.1.1 and the BA.2 linage recombination XBB, XBB.1.5 and XBB.1.16, have emerged following the BA.2 and BA.5 subvariants. Remarkably, BQ.1.1 and XBB showed substantial neutralization escape as compared with the previous variants, and have gradually become the dominant variants worldwide.1 These facts emphasize the urgency of identifying highly conserved SARS-CoV-2 epitopes, which would be essential for the design of universal vaccines and broadly neutralizing antibodies.
We first explored whether a previously reported bispecific single-domain antibody bn03 could resist the immune escape of the SARS-CoV-2 Omicron variants by neutralization and binding activities.2 As shown in Fig. 1a, bn03 could broadly neutralize all the six Omicron variants, with IC50 values of 0.69, 0.36, 1.50, 0.10, 0.59 and 0.74 μg/ml for BA.2, BA.4, BA.5, BF.7, BQ.1.1 and XBB, respectively, which is comparable to that of the five SARS-CoV-2 variants of concern (VOCs Alpha, Beta, Gamma, Delta and Omicron BA.1, ranging from 0.11–0.76 μg/mL2). Correspondingly, bn03 exhibited potent binding to the RBD of BQ.1.1 and XBB spikes (S) (Fig. 1b, c).
Analysis of mutational events across SARS-CoV-2 variants revealed that the n3130v domain of bn03 contributed to its exquisite neutralizing breadth (Supplementary Fig. 1). This domain was found to recognize a cryptic region located in the spike trimeric interface.3 Therefore, to precisely decipher the conserved epitopes, we not only determined the cryoelectron microscopy (cryo-EM) structure of bn03 in complex with the prefusion-stabilized SARS-CoV-2 Omicron XBB spike, but also the complexes of n3130v with spikes of XBB and BQ.1.1. In contrast to the apo-state spike trimers which mostly have one-RBD up and two-RBD down (UDD), two states of XBB spike were observed when incubated with bn03 for ten minutes: the spike trimers with one RBD up (UDD) and mostly, the spike monomer in complex with bn03 (XBB S-bn03) (Supplementary Figs. 2b, 3). Therefore, bn03 binding tends to disassemble the trimers into monomers. After an hour of incubation with bn03, most S trimers were disassembled (Supplementary Fig. 2b). Similarly, the mixture of n3130v with XBB (XBB S-n3130v) or BQ.1.1 spikes for an hour resulted in extensive trimer disassembly (Fig. 1f, h, Supplementary Fig. 2c, e). Such phenomenon was also observed in two other reported antibodies, S2H97 and 553–49, that target epitopes buried inside the spike trimer.4,5 Taken together, these results clearly demonstrate spike trimer disassembly as mechanism of action for the antibodies targeting trimeric interface epitopes.
In XBB S-bn03 complex, due to the flexibility of S monomer, the S1 (NTD-RBD-SD1-SD2) region and the n3130v domain of bn03 was locally refined to 3.98 Å resolution. The complex structures of XBB spike monomer-n3130v (XBB S-n3130v) and BQ.1.1 spike monomer-n3130v (BQ.1.1 S-n3130v) were determined to 3.44 Å and 3.68 Å, respectively (Supplementary Figs. 4, 5; Supplementary Table 1). The three complex structures revealed nearly identical binding epitopes that buried deep inside the trimeric interface of the spike proteins (Fig. 1d, e, g, i). A total of 38 residues from XBB S-RBD are involved, rendering 1391.6 Å2 buried surface area of the XBB spike monomer. These extensive contacts are mediated by both hydrophilic and hydrophobic interactions and all three CDRs of n3130v are involved (Fig. 1e, j). D30 of CDR1 forms a salt bridge with K462 of RBD. S52, L54 and G55 of CDR2 contacts R355, Y396, and E516 of RBD through six pairs of hydrogen bonds. R99 and P101 of CDR3 form three hydrogen bonds with L517 of RBD (Fig. 1k). F429 and F464 of RBD form a hydrophobic interface with Y31 and P102 of n3130v (Fig. 1i). Other than that, F562 and F565 of SD1 form another hydrophobic interface with V37, L45, Y95, A97, F107, W110 of n3130v (Fig. 1m), which is not observed in BA.1 S trimer-bn03 complex structure4 (PDB ID: 7WHK). Compared with BA.1 S trimer-bn03 complex, the S1 region of XBB S in S monomer-n3130v complex undergoes large conformational changes (Supplementary Fig. 6, Supplementary Video 1), inserting F562 and F565 residues of the SD1 domain into the hydrophobic groove of n3130v (Fig. 1m) and thus providing stronger interaction between S1 and 3130v. The n3130v epitopes on RBD and SD1 are highly conserved between the variants of SARS-CoV-2, including WT, BA.1, BQ.1.1, XBB, XBB.1.5 and the newly discovered XBB.1.16 (Supplementary Fig. 1). The highly conserved epitopes explain the exquisite neutralizing breadth of bn03. The relatively low immune pressure may contribute to the high conservation of such trimeric interface epitope.
In summary, our study defined a highly conserved epitope on the trimeric interface of viral spikes that enables broad antibody recognition of SARS-CoV-2 variants including the Omicron subvariants BQ.1.1 and XBB, and emphasized a unique mechanism for antibody neutralization via inducing SARS-CoV-2 spike trimer decay and disassembly.
Data availability
The cryo-EM maps and the coordinates of SARS-CoV-2 Omicron S variants complexed with bn03 or n3130v have been deposited to the Electron Microscopy Data Bank (EMDB) and Protein Data Bank (PDB) with accession numbers EMD-35170 and PDB 8I4E (XBB S-bn03), EMD-35171 and PDB 8I4F (XBB S-n3130v), EMD-35172 and PDB 8I4G (BQ.1.1 S-n3130v), EMD-35173 and PDB 8I4H (BA.1 S-bn03).
References
Miller, J. et al. Substantial neutralization escape by SARS-CoV-2 omicron variants BQ.1.1 and XBB.1. N. Engl. J. Med. 388, 662–664 (2023).
Li, C. et al. Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody. Cell 185, 1389–1401 e1318 (2022).
Wu, Y. et al. Identification of human single-domain antibodies against SARS-CoV-2. Cell Host Microbe 27, 891–898.e895 (2020).
Starr, T. N. et al. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature 597, 97–102 (2021).
Zhan, W. et al. Structural study of SARS-CoV-2 antibodies identifies a broad-spectrum antibody that neutralizes the omicron variant by disassembling the spike trimer. J. Virol. 96, e0048022 (2022).
Acknowledgements
We thank Center of Cryo-Electron Microscopy, Fudan University for the supports on cryo-EM data collection. This work was supported by grants from the Ministry of Science and Technology of China (2019YFA0904400 to TY, 2021YFC2302500 to LS), National Natural Science Foundation of China (32270984, 32270142), Shanghai Municipal Science and Technology Major Project (ZD2021CY001), and by R&D Program of Guangzhou Laboratory (SRPG22-003 to LS).
Author information
Authors and Affiliations
Contributions
T.Y., Y.W. and L.S. conceived, wrote the paper, and supervised the study. A.H., W.S., C.L., X.Z., C.T., X.W. and P.W. performed the experiments and analyzed the data. All authors reviewed and approved the final version of the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hao, A., Song, W., Li, C. et al. Defining a highly conserved cryptic epitope for antibody recognition of SARS-CoV-2 variants. Sig Transduct Target Ther 8, 269 (2023). https://doi.org/10.1038/s41392-023-01534-0
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41392-023-01534-0
This article is cited by
-
Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein
Nature Communications (2024)